Article ID Journal Published Year Pages File Type
10052057 The Journal of Urology 2005 7 Pages PDF
Abstract
Intravesical BCG significantly reduces the risk of short and long-term treatment failure compared with intravesical chemotherapy. Therefore, it is considered to be the intravesical agent of choice in the treatment of CIS.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Preview
BACILLUS CALMETTE-GUERIN VERSUS CHEMOTHERAPY FOR THE INTRAVESICAL TREATMENT OF PATIENTS WITH CARCINOMA IN SITU OF THE BLADDER: A META-ANALYSIS OF THE PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALS
Authors
, , , ,